HomeAI · summaries
Storia in 7 fonti
"Momentum Continues": Lilly Jumps After Raising Revenue Outlook On Surging GLP-1 Demand
"At the same time, Lilly is building for the future. With our next-generation weight-loss medicine..."
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
independent.co.uk
GLP-1 battle heats up again as Novo claws its way back into race with Lilly
The two pharmaceutical giants are locked in a fierce battle for dominance in the burgeoning obesity drug market
- ·
forbes.com
Eli Lilly’s Obesity Drugs Drive Massive Revenue Growth
In this week’s edition of InnovationRx, we look at Lilly’s 2Q earnings, a cannabis-derived drug for PTSD, Apnimed’s IPO and more
